Oddity Tech Ltd. (ODD) is a consumer-technology company that builds digital-first beauty and wellness brands, chiefly IL MAKIAGE and SpoiledChild, alongside the newer METHODIQ telehealth brand. It is a stock, not an exchange-traded fund. Its analyst picture is unusually lopsided: the prevailing consensus rating is Hold, and the average twelve-month price target sits near $16–$17, below the current share price of about $19.90.
Because the aggregate analyst target is below the market price, it cannot serve as a meaningful upside objective. The $30 figure instead comes from public, identifiable research: KeyBanc's Buy-rated price target, the highest on the Street. For context, the full range runs from roughly $8 (Goldman Sachs and Barclays) to $30, with recent actions including Morgan Stanley's $18.50 target (October 2026), J.P. Morgan's $18 reinstatement, Truist and Jefferies at $18, and Bank of America at $10. Analysts disagree sharply because the debate is whether 2026's contraction was temporary or structural.
With shares near $19.90, reaching $30 would require an increase of approximately 51%, a very large move. The stock's 52-week range is wide, from about $9.25 to $46.45, reflecting a steep drawdown followed by a partial recovery. Third-quarter results, reported in November 2026, showed adjusted earnings per share (EPS) of $0.37 versus a $0.30 consensus, while revenue of roughly $145 million declined only 2% year over year, a sharp improvement from declines of about 25% in the prior two quarters.
The path toward a higher price would likely require sustained revenue inflection, resolution of the IL MAKIAGE advertising-account dislocation, and a recovery in margins that compressed to 67.4% gross margin from 71.6% a year earlier. A return toward $30 would also require the market to re-rate the stock after its forward P/E (price-to-earnings) multiple reset from earlier elevated levels.
The stock has recovered substantially from its 52-week low near $9.25 but remains well below its 52-week high near $46.45. Shares have been trading through the high-teens and low-$20s, making the $20 psychological level a nearby reference point. A durable move toward $30 would first need to clear prior resistance in the low-to-mid-$20s before approaching higher zones established earlier in the year. The wide trading range and a beta above 2.0 underscore the stock's elevated volatility.
Analyst price targets typically reflect a roughly twelve-month research horizon, though KeyBanc's $30 target was established earlier in 2026 and may reflect a longer recovery path. Investors should watch for evidence that the IL MAKIAGE advertising issue is resolving, customer-acquisition-cost trends, SpoiledChild and METHODIQ growth, fourth-quarter guidance, and any analyst target revisions following the latest earnings. Margin recovery and free-cash-flow generation are also key signposts toward a sustainable re-rating.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals as market conditions, technical behavior, and AI-driven analysis evolve. Traders can use the tool to surface opportunities, keep an eye on existing positions, and detect changing trends more efficiently than manual screening allows. For those following volatile names like ODD, automated signal monitoring can help identify shifts in momentum as they develop.
The $30 level for ODD is not a consensus forecast; it is the highest single analyst price target, from KeyBanc, and would require a gain of about 51% from current levels. Supportive factors include stabilizing revenue, an earnings beat, and momentum in newer brands, but the unresolved IL MAKIAGE issue, margin erosion, and a consensus that still implies downside are substantial obstacles. The wide $8-to-$30 analyst range reflects genuine disagreement about the durability of the recovery, and no outcome should be treated as certain. Investors should monitor advertising-cost normalization, brand-level growth, and upcoming guidance before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, ODD has been loosely correlated with ALIT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ODD jumps, then ALIT could also see price increases.
| Ticker / NAME | Correlation To ODD | 1D Price Change % | ||
|---|---|---|---|---|
| ODD | 100% | +5.38% | ||
| ALIT - ODD | 37% Loosely correlated | +5.67% | ||
| RBRK - ODD | 37% Loosely correlated | -0.45% | ||
| CPAY - ODD | 37% Loosely correlated | +1.36% | ||
| ZS - ODD | 37% Loosely correlated | -0.39% | ||
| TOST - ODD | 33% Loosely correlated | +3.46% | ||
More | ||||
| Ticker / NAME | Correlation To ODD | 1D Price Change % |
|---|---|---|
| ODD | 100% | +5.38% |
| Household/Personal Care industry (30 stocks) | 25% Poorly correlated | +2.55% |
| Consumer Non Durables industry (179 stocks) | 11% Poorly correlated | +0.20% |